Key Market Indicator:
F&G: 63
25.143,30 NASDAQ · 49.017,00 DOW · 6.873,90 S&P · 4.671,72 Gold · 63,10 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© EQS Newswire
17.06.2025
ISIN: DE0005785802
Fresenius Medical Care AG
FME
LISTED
XETR
Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von EUR 1 Milliarde in mehreren Tranchen innerhalb von 2 Jahren
Article
News Preview
Bad Homburg, 17. Juni 2025 - Die Fresenius Medical Care AG („Gesellschaft“) hat beschlossen, ein Aktienrückkaufprogramm mit einem Volumen von EUR 1 Milliarde (ohne Erwerbsnebenkosten) in mehreren Tranchen innerhalb von zwei Jahren ab dem Start des Programms durchzuführen. Es ist geplant, die Durchführung des Aktienrückkaufprogramms in mehreren Tra......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
ISIN: DE0005785802
Fresenius Medical Care AG
FME
LISTED
XETR
Fresenius Medical Care AG resolves share buyback program with a total volume of EUR 1 billion in tranches within 2 years
Article
News Preview
Bad Homburg, June 17, 2025 – Fresenius Medical Care AG (“Company”) has decided to conduct a share buyback program with a volume of EUR 1 billion (excluding ancillary costs) in tranches within two years after the start of the program. The execution of the share buyback program in tranches is planned to commence in the second half of 2025. The share......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon plant öffentliche Unternehmensanleihe zur Unterstützung der nächsten Wachstumsphase im attraktiven Biosimilar-Markt
Article
News Preview
Pressemitteilung // 17. Juni 2025   Formycon plant öffentliche Unternehmensanleihe zur Unterstützung der nächsten Wachstumsphase im attraktiven Biosimilar-Markt Unbesicherte Anleihe 2025/2029 hat Zielvolumen von 50 Mio. Euro und ist variabel verzinst Erlöse unterstützen gezielte Weiterentwicklung des Biosimilar-Produktportfolios und die Umsetzun......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
17.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon plans public corporate bond issuance to support next growth phase within attractive Biosimilar markets
Article
News Preview
Press Release // June 17, 2025 Formycon plans public corporate bond issuance to support next growth phase within attractive Biosimilar markets Unsecured bond 2025/2029 with a target volume of EUR 50 million and variable interest rate Proceeds will support the targeted development of biosimilar product portfolio and the execution of the next grow......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
17.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon plant Begebung einer unbesicherten und variabel verzinslichen öffentlich handelbaren Anleihe mit einem Zielvolumen von EUR 50 Mio. zur Unterstützung des weiteren Unternehmenswachstums
Article
News Preview
Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014 NICHT ZUR VERBREITUNG, VERÖFFENTLICHUNG ODER WEITERGABE, DIREKT ODER INDIREKT, IN ODER INNERHALB DER VEREINIGTEN STAATEN VON AMERIKA, KANADA, AUSTRALIEN, JAPAN ODER ANDEREN LÄNDERN, IN DENEN DIE VERBREITUNG ODER VERÖFFENTLICHUNG RECHTSWIDRIG SEIN KÖNNTE. ES ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.06.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon plans to issue a public senior unsecured floating rate bond with target volume of EUR 50 million to support further company growth
Article
News Preview
Disclosure of Inside Information Pursuant to Article 17 of Regulation (EU) No. 596/2014 NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE ......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
Article
News Preview
ORION CORPORATION PRESS RELEASE 17 JUNE 2025 at 9.00 EEST        ...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
TEMPUS AI SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM
Article
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against Tempus AI, Inc. (NasdaqGS: TEM), if they purchased the Company’s shares between August 6, 2024 and May...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.06.2025
ISIN: GB0034330679
CelLBxHealth plc
CLBX
LISTED
AIMX
Angle PLC - EACR 2025: Data Demonstrating DNA Dual Analysis
Article
News Preview
ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILINGPoster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour heterogeneity in lung cancer patients GUILDFORD, SURREY / ACCESS Newswire / June 17, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy compa...
Themefolio
Profiler
Peergroup
© BusinessWire
16.06.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Article
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. (“Tempus” or “the Company”) (NASDAQ: TEM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investor...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.06.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
16.06.2025
ISIN: SE0000135485
RaySearch Laboratories AB (publ)
RAY B
LISTED
STO
RayStation used for pioneering clinical milestone at Helsinki University Hospital - first treatment with accelerator-based BNCT in Europe
Article
News Preview
STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' accelerator-based boron neutron capture therapy (BNCT), carried out on a patient at Helsinki University Hospital i...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.06.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Canadian hospital system leverages Sectra's AI service to enhance patient care and workflow efficiency
Article
News Preview
LINKÖPING, Sweden and MISSISSAUGA, ON, June 16, 2025 /PRNewswire/ -- William Osler Health System (Osler) in Canada leverages AI through the international medical imaging IT and cybersecurity company Sectra's (STO: SECT B) AI service, Sectra Amplifier Service. This collaboration enables Osler to seamlessly integrate selected AI applications into t...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.06.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Article
News Preview
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging
Article
News Preview
Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on standard-of-care (SOC) scans, including prostate-specific membrane antigen (PSMA) Positron Emissio...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
Article
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
ISIN: CA23256X4075
Cybin Inc.
HELP
LISTED
NASDAQ
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics
Article
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today provided a corporate update. “It is especially gratifying that at a time when we are advan...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025
Article
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R bispecific antibody, demonstrating its ability to simultaneously suppress the inflammatory and pruritogenic (itch-causing) pathways in atopic dermatitis (AD). The findings, featured during a poster present...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review
Article
News Preview
STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed...
Themefolio
Profiler
Peergroup
© PR Newswire
13.06.2025
ISIN: SE0010323311
BioArctic AB
BIOA B
LISTED
STO
BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review
Article
News Preview
STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a study EXIST showed exidavnemab to be safe and well-tolerated, whereby the second dose cohorts will now be initiated. The EXIST study evaluates exidavnemab, a drug candidate being developed...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies to Participate in Upcoming EAACI Congress 2025
Article
News Preview
Châtillon, France, June 12, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: BE0003818359
Galapagos NV
GLPG
LISTED
EURONEXT
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
Article
News Preview
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 12 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparan...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – June 12, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on June 11, 2025, from Atlas...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This multi-year collaboration aims to harness AI for rapid discovery and innovation i...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
ISIN: US2290503075
Cryoport Inc
CYRX
LISTED
NASDAQ
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
Article
News Preview
NASHVILLE, Tenn., June 12, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain solutions for the Life Sciences, with a focus on regenerative medicine, today announced the completion of the previously disclosed divestiture of its specialty courier business, CRYOPDP, to D...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum
Article
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the Citizens Medical Devices...
Themefolio
Profiler
Peergroup
© BusinessWire
12.06.2025
ISIN: CA23256X4075
Cybin Inc.
HELP
LISTED
NASDAQ
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
Article
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a virtual...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
Article
News Preview
BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. La...
Themefolio
Profiler
Peergroup
© PR Newswire
12.06.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi share new clinical data across multiple hematologic diseases at EHA 2025
Article
News Preview
STOCKHOLM, June 12, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will feature the latest advances in the treatment of diffuse large B-cell lymphoma (DLBCL), immune thrombocytopenia (ITP), myelofibrosis, paroxysmal nocturnal h...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Major shareholder announcement
Article
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis
Article
News Preview
Leuven, BELGIË – 12 juni 2025 – 8u30 CET – Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, kondigt aan dat de opschortende voorwaarde met betrekking tot het voorafgaand informatie- en raadplegingsrecht van de werknemers, overeenkomstig artikel L.23-10-1 van het Franse Wetboek van...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion moves forward with the planned acquisition of Axiodis
Article
News Preview
Leuven, BELGIUM – June 12, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the lifting of the condition precedent relating to the completion of the employee information process as per Article L.23-10-1 of the French Commercial Code. This milestone represents a key step towards...
Themefolio
Profiler
Peergroup
© ActuNews
12.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion avance dans l'acquisition projetée d'Axiodis
Article
News Preview
Louvain, BELGIQUE – 12 juin 2025 – 8h30, Oxurion NV (Euronext Bruxelles : OXUR), société biopharmaceutique basée à Louvain, annonce la levée de la condition suspensive relative au droit d'information préalable des salariés, conformément à l'article L.23-10-1 du Code...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: FR0010386334
Clariane SE
CLARI
LISTED
EURONEXT
Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network
Article
News Preview
        ...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.06.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
Article
News Preview
COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV VLP in children 2 to 11 years of age....
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue
Article
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary revenue for its third fiscal quarter and updated its full year 2025 revenue gu...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
Article
News Preview
Châtillon, France, June 11, 2025...
Themefolio
Profiler
Peergroup
© ActuNews
11.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIUM – June 11, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on June 9, 2025, from Atlas Sp...
Themefolio
Profiler
Peergroup
© ActuNews
11.06.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Article
News Preview
Leuven, BELGIË – 11 juni 2025 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgevingen heeft ontvangen: Oxurion ontving een transparan...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
Article
News Preview
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
11.06.2025
ISIN: CA23256X4075
Cybin Inc.
HELP
LISTED
NASDAQ
Cybin to Participate in the 2025 Psychedelic Science Conference
Article
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the Psych...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
ISIN: GB00BDFBVT43
Oxford Biomedica PLC
OXB
LISTED
LSE
AGM Update
Article
News Preview
Oxford, UK – 11 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to coincide with its Annual General Meeting being held at 3pm BST today at Windrush Court, Oxford, UK....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
ISIN: US45783C2008
Instil Bio Inc
TIL
LISTED
NASDAQ
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
Article
News Preview
DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Instil’s wholly-owned subsidiary dedicated to the development of...
Themefolio
Profiler
Peergroup
© PR Newswire
11.06.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to attend BIO International Convention
Article
News Preview
LUND, Sweden, June 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that Hansa's CEO Renée Aguiar-Lucander will speak at the BIO International Convention at the Boston Convention & Exhibition Center, Boston, MA, June 16-19. Aguiar-Lucander will participate in a panel entitled "European Biotech: U...
Themefolio
Profiler
Peergroup
© PR Newswire
11.06.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to attend BIO International Convention
Article
News Preview
LUND, Sweden, June 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that Hansa's CEO Renée Aguiar-Lucander will speak at the BIO International Convention at the Boston Convention & Exhibition Center, Boston, MA, June 16-19. Aguiar-Lucander will participate in a panel entitled "European Biotech: U...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.06.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO
Article
News Preview
SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO Andreas Reisse’s contract as CEO of SCHOTT Pharma extended CFO Dr. Almuth Steinkühler to leave the company at her own request to pursue new professional opportunities Reinhard Mayer appointed as new CFO of SCHOTT Pharma The Supervisory B......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.06.2025
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
SCHOTT Pharma Aufsichtsrat verlängert Vertrag von CEO Andreas Reisse und ernennt Reinhard Mayer zum neuen CFO
Article
News Preview
SCHOTT Pharma Aufsichtsrat verlängert Vertrag von CEO Andreas Reisse und ernennt Reinhard Mayer zum neuen CFO Der Vertrag von SCHOTT Pharma CEO Andreas Reisse wird verlängert CFO Dr. Almuth Steinkühler verlässt das Unternehmen auf eigenen Wunsch, um sich neuen beruflichen Herausforderungen zu widmen Reinhard Mayer wird CFO von SCHOTT Pharma Der......
Themefolio
Profiler
Peergroup
© BusinessWire
10.06.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
Article
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.06.2025
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
Article
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova Aktionäre stimmen allen Anträgen des Verwaltungsrates zu
Article
News Preview
Sonova Holding AG / Schlagwort(e): Generalversammlung Ordentliche Generalversammlung 2025: Sonova Aktionäre stimmen allen Anträgen des Verwaltungsrates zu 10.06.2025 / 13:00 CET/CEST Group Media & Investor Release Stäfa (Schweiz), 10. Juni 2025 – Sonova Holding AG (SWX: SOON), ein führender Anbieter innovativer Hörl......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.06.2025
ISIN: CH0012549785
Sonova Holding AG
SOON
LISTED
SIX
Sonova shareholders approve all Board of Directors motions
Article
News Preview
Sonova Holding AG / Key word(s): AGMEGM Annual General Shareholders’ Meeting 2025: Sonova shareholders approve all Board of Directors motions 10.06.2025 / 13:00 CET/CEST Group Media & Investor Release Stäfa (Switzerland), June 10, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of innovative hearing care so......
Themefolio
Profiler
Peergroup
© Globe Newswire
10.06.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Transactions in Connection with Share Buy-back Program
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© BusinessWire
09.06.2025
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 128,750 common...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.06.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
Article
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.06.2025
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
TransCon® hGH Boosted Treatment Benefits of TransCon® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
Article
News Preview
- For the TransCon CNP treatment-naïve cohort, combination treatment resulted in mean annualized growth velocity (AGV) of 9.14 cm/year, with an improvement in mean ACH height Z-score of +0.53 over 26 weeks...
Themefolio
Profiler
Peergroup
© PR Newswire
09.06.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
Article
News Preview
LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, June 16, 2025 at 14:00 CEST / 8:00 AM EDT. Pre-registration is required and can be found at this link. Presentations by Dr. David R. Cornblath, MD,...
Themefolio
Profiler
Peergroup
© PR Newswire
09.06.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
Article
News Preview
LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, June 16, 2025 at 14:00 CEST / 8:00 AM EDT. Pre-registration is required and can be found at this link. Presentations by Dr. David R. Cornblath, MD,...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.06.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
Article
News Preview
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 19.01.2026, Calendar Week 04, 19th day of the year, 346 days remaining until EoY.